• 10 Sep 2019

SP Angel Healthcare Conditions

Polarean Imaging, 35.5 | Tiziana Life Sciences, 40.0

    • Vadim Alexandre

    • 4 pages

Medical Equipment & Services image


 
Medical Equipment & Services image


Polarean Imaging (POLX.L): New System Installation | Tiziana Life Sciences (TILS.L): Phase 1 data for Foralumab


Sign up to access

Get access to our full offering from over 30 providers

Get access to our full offering from over 30 providers


Get Started
Already a member? Log in here

More Content

More Content

SP Angel Healthcare Conditions

Companies: Polarean Imaging Verona Pharma

Polarean Imaging plc - First patient in Phase III FDA Clinical Trial

Companies: Polarean Imaging

SP Angel Healthcare Conditions

Companies: Tiziana Life Sciences Circassia Pharmaceuticals

Polarean Imaging eagerly awaiting readouts from its key phase III clinical trials

Companies: Polarean Imaging

SP Angel Healthcare Conditions

Companies: Beximco Pharmaceuticals Polarean Imaging

Copyright © 2020 Research Tree | All Rights Reserved. | Terms of Service and Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Tools licensed and contents implemented and optimized by Digital Look Ltd.

DigitalLook |Web Financial Group

©1999-2013 – Digital Look Ltd. A Web Financial Group Company All rights reserved. Legal notice.

Top